What Has Led Bristol-Myers Squibb's Stock To Fall More Than 35% Over The Last 3 Years?

Bristol-Myers Squibb's (NYSE:BMY) stock price has fallen by over 35% over the last three years, despite a growth in revenues, margins, and earnings. The decline can be attributed only to contraction in the price to earnings multiple. In this note we discuss the factors that led to the stock price...